Trial
NCT01904643
Lenalidomide and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Stanford University
Collaborators
National Cancer Institute (NCI)
Condition
Adult Acute Megakaryoblastic Leukemia (M7)
Intervention
lenalidomide
Why stopped
Accrual factor
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-10-29